While some progress has been made to disseminate comparative effectiveness research as mandated by the Affordable Care Act, the Agency of Healthcare Research and Quality has not taken actions to fully address requirements, according to a report from the Government Accountability Office.
While some progress has been made to disseminate comparative effectiveness research (CER) as mandated by the Affordable Care Act (ACA), the Agency of Healthcare Research and Quality (AHRQ) has not taken actions to fully address requirements, according to a report from the Government Accountability Office (GAO).
The agency has created tools to organize and disseminate research findings, but it has not defined clear time frames for implementation and distribution of information and tools to certain stakeholder groups specified in the law.
“While HHS has multiple, ongoing efforts to meets its requirements under [ACA} related to CER, it has not determined how it will fully address some of these requirements, particularly those related to dissemination and data capacity building,” according to the report.
CER could help patients and providers make better healthcare decisions by providing more complete clinical information; however, the availability of this information remains limited.
“Disseminating CER in a timely manner is particularly challenging given the length of time and uncertainty inherent in applying research findings to help improve health care practice,” the authors of the report wrote.
According to the report, while HHS has coordinated various agencies to build data capacity for CER, its approach lacks effectiveness because it needs defined objectives, milestones, and time frames.
As of February 2014, the strategic framework for a roadmap to enable the collection of standardized clinical data and other priorities objectives were only broadly outlined and not defined, according to GAO. For instance, the roadmap is unclear on the timing and coordination necessary to improve data capacity.
The report also provides 4 recommended actions that can be taken by AHRQ, all of which HHS concurs:
1. Identify and document time frames for the implementation and distribution of marketing plans and information tools.
2. Expand dissemination efforts to federal and private health plans and vendors of health information technology focused on clinical decision support.
3. Document and complete plans to develop a publicly available database.
4. Develop specific plans on how it will collaborate with the National Institutes of Health on dissemination activities.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Reducing Time Sitting Can Help Lower BP in Older Adults, Randomized Trial Finds
April 20th 2024The randomized trial found that reducing sitting time over a 6-month period was association with reduced systolic blood pressure (BP) among a group of older patients with obesity and high rates of hypertension.
Read More
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More